Monday, April 14, 2008

Codexis Eyes Market

Redwood City-based Codexis is eyeing an IPO on the NASDAQ Global Market, saying in a filing with the SEC Monday that it hopes to raise up to $100M in an offering. The IPO is being underwritten by Credit Suisse, Goldman, Sachs & Co., Piper Jaffray, RBC Capital Markets, and Thomas Weisel Partners LLC. Codexis develops biocatalysts used for chemical manufacturing processes, including pharmaceuticals and biofuels. Codexis is backed by Maxygen, Biomedical Sciences Investment Fund Pte Ltd, Shell Oil, CMEA Ventures, Pequot Capital, and CTTV Investments, the investment arm of Chevron.